Below are the most recent publications written about "Antiviral Agents" by people in Profiles.
-
Esposito N, Viceconte G, Festa L, Alf? FA, Carriero C, Codella AV, Glielmo A, Forgione L, Buonomo AR, Muccio FC, Lamberti M, Alfano R, Coppola MG, Megna AS, Gentile I. Outbreak of Human Neuroinvasive West Nile Virus Infection in Campania, Italy, August-September 2024. Vector Borne Zoonotic Dis. 2025 Sep; 25(9):565-567.
-
Kim J, Lim JW, Kim HO, Park J, Jeong E, Park C, Park G, Yeom M, Song D, Lim EK, Haam S. Hemagglutinin docking analysis-based visual detection of antiviral therapeutic efficacy of umifenovir against influenza virus. Biosens Bioelectron. 2025 Nov 01; 287:117762.
-
Sharma T, Mondal T, Saralamma VVG, Hassan MI, Kim CJ, Churqui MP, Nystr?m K, Thombare K, Baig MH, Dong JJ. Exploring the exportin-1 inhibitors for COVID-19 and anticancer treatment. J Biomol Struct Dyn. 2026 Jan; 44(1):463-474.
-
Kashikar R, Kotha AK, Shrestha R, Channappanavar R, Chougule MB. Formulation and In-Vitro Testing of Nebulized Camostat Mesylate Loaded Nanoliposomes for the Treatment of SARS-CoV- 2 Infection. AAPS PharmSciTech. 2025 May 16; 26(5):139.
-
Uwamahoro H, Collier WE, Nashar TO, Jaynes JM, Mortley DG, Davis CG, Kanyairita GG, Abdelazim EF, Igiramaboko JFR, Habineza C, Tumushimiyimana D, Rutayisire UN, Davis YA, Renard KL. Natural and Designed Cyclic Peptides as Potential Antiviral Drugs to Combat Future Coronavirus Outbreaks. Molecules. 2025 Apr 08; 30(8).
-
Maison DP, Tasissa H, Deitchman A, Peluso MJ, Deng Y, Miller FD, Henrich TJ, Gerschenson M. COVID-19 clinical presentation, management, and epidemiology: a concise compendium. Front Public Health. 2025; 13:1498445.
-
Adeyinka OS, Barrera MD, Metibemu DS, Boghdeh N, Anderson CA, Baha H, Crown O, Falode JA, Bleach JL, Bliss AR, Hampton TP, Ojobor JC, Alem F, Narayanan A, Ogungbe IV. nsP2 Protease Inhibitor Blocks the Replication of New World Alphaviruses and Offer Protection in Mice. ACS Infect Dis. 2025 Jan 10; 11(1):181-196.
-
VanKoten HW, Pence BC, Klinkenberg JR, Das S, Patterson SE. Synthesis and evaluation of anti-Giardia activity of oseltamivir analogs. Bioorg Med Chem Lett. 2025 Feb 01; 116:130035.
-
Ruiz-Molina A, Pech-Puch D, Mill?n RE, Ageitos L, Villegas-Hern?ndez H, Pach?n J, P?rez Sestelo J, S?nchez-C?spedes J, Rodr?guez J, Jim?nez C. Uncovering the Potent Antiviral Activity of the Sesterterpenoids from the Sponge Ircinia Felix Against Human Adenoviruses: from the Natural Source to the Total Synthesis. Chemistry. 2024 Nov 26; 30(66):e202401844.
-
Travis JK, Costantini LM. Inhibiting KSHV replication by targeting the essential activities of KSHV processivity protein, PF-8. J Med Virol. 2024 Oct; 96(10):e29958.